Clinical Trials Directory

Trials / Completed

CompletedNCT02924532

Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy

Diagnostic Value of Immediate Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy: A Retrospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to establish an optimal threshold Early parathormon (PTH) assay in order to exclude hypoparathyroidism , that is to say to obtain a negative predictive value of hypoparathyroidism highest possible.

Conditions

Interventions

TypeNameDescription
BIOLOGICALimmediate post operative bioassay of Parathyroid Hormone

Timeline

Start date
2012-02-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2016-10-05
Last updated
2025-11-21

Source: ClinicalTrials.gov record NCT02924532. Inclusion in this directory is not an endorsement.